| Date | Quarter | Session | EPS (est → actual) | Revenue (est → actual) |
|---|---|---|---|---|
| Nov 16, 2026Next | Q2 2027 | — | 1.36 | 9.58 B |
Sep 2, 2026
In August 2026, Merit Medical Systems announced that Sheri Lewis would join as Executive Vice President of Global Operations, bringing three decades of global manufacturing and supply chain experience from SkinHealth Systems, Avantor, Medtronic, and Honeywell, while long-time operations leader Mr. Peterson shifted to a Senior Advisor role through March 2027 to support continuity. This leadership transition highlights Merit's focus on strengthening global operations and supply chain...
Sep 1, 2026
Moby summary of Medtronic plc's Q1 2027 earnings call
Medtronic plc will release its first earnings report before the opening bell on Tuesday, Sept. 1. Analysts expect the company to report quarterly earnings of $1.39 per share, up from $1.26 per share in the year-ago period. The consensus estimate...
Tesla trades lower even as investors anticipate the potential entry of Cybercab into the company’s fleet of self-driving cabs.
Medtronic PLC (MDT) reports robust Q1 FY2027 results with 13.7% organic growth, driven by Cardiac Ablation Solutions and broad-based strength, while raising full-year guidance.
Tesla trades lower even as investors anticipate the potential entry of Cybercab into the company’s fleet of self-driving cabs.
Medtronic stock popped Tuesday as its diabetes spinoff MiniMed rallied after both lifted their full-year guidance.
MDT beats Q1 earnings and revenue estimates as broad-based growth drives shares higher and prompts a fiscal 2027 guidance boost.
Medtronic stock popped Tuesday as its diabetes spinoff Minimed rallied after both lifted their full-year guidance.
Medtronic (NYSE:MDT) reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted earnings per share of $1.45, as the medical-device maker cited broad-based demand, commercial execution and momentum in several growth platforms. Revenue increased 13.7% on both a reported and organic basis
Medtronic plc (NYSE:MDT) shares rose 5% after the medical device company reported first-quarter fiscal 2027 results above analyst expectations and increased its full-year revenue growth and earnings guidance. Adjusted earnings per share came in at $1.
Although the revenue and EPS for Medtronic (MDT) give a sense of how its business performed in the quarter ended July 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medtronic plc (MDT) Q1 2027 Earnings Call September 1, 2026 7:45 AM EDTCompany ParticipantsIngrid Goldberg - Vice President & Head of Investor...
Medtronic (MDT) lifted its full-year outlook on Tuesday as the medical-device maker reported better-
Medtronic (NYSE:MDT) has made an investment in Pi-Cardia to expand its structural heart device portfolio for complex transcatheter aortic valve replacement procedures. The agreement gives Medtronic rights to distribute Pi-Cardia's leaflet modification device, the first FDA cleared tool designed to support valve in valve TAVR in patients at risk of coronary obstruction. The move is aimed at addressing more complex aortic valve cases and broadening treatment options for cardiologists and their...
Medtronic plc recently announced a partnership with Cornerstone Robotics, committing about US$700 million and securing rights to distribute Cornerstone’s Sentire surgical system in select approved markets outside the U.S., where it will be offered alongside Medtronic’s Hugo robotic-assisted surgery platform. This move effectively broadens Medtronic’s robotic surgery portfolio, giving hospitals and surgeons more choice across complementary platforms that can plug into the company’s connected...
BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $91 to $100.
The medical device maker grew revenue by double digits in its fiscal first quarter, following fourth-quarter growth of nearly 10%.
Medtronic (MDT) delivered earnings and revenue surprises of +4.32% and +3.02%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
Investing.com -- Medtronic plc (NYSE: MDT) reported first-quarter fiscal 2027 results that exceeded analyst expectations, with shares rising 5% as the medical device maker raised its full-year outlook on strength across its portfolio.
